Control of drug release with a combination of prodrug and polymer matrix: Antitumor activity and release profiles of 2′, 3′-diacyl-5-fluoro-2′-deoxyuridine from poly(3-hydroxybutyrate) microspheres
✍ Scribed by Takeo Kawaguchi; Akiko Tsugane; Kumiko Higashide; Hirotaka Endoh; Tetsuya Hasegawa; Hiromi Kanno; Toshinobu Seki; Kazuhiko Juni; Shoji Fukushima; Masahiro Nakano
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 488 KB
- Volume
- 81
- Category
- Article
- ISSN
- 0022-3549
No coin nor oath required. For personal study only.
✦ Synopsis
Drug release was controlled by a combination of prodrug and polymer matrix. Prodrugs of 5-fluoro-2'-deoxyuridine with different physicochemical properties were synthesized by esterification with aliphatic acids (propionate, n-butyrate, and n-pentanoate). Microspheres containing these ester prodrugs were prepared with poly(3-hydroxybutyrate) of three molecular weights (65,000, 135,000, and 450,000). The release rates from the spheres depended on both the lipophilicity of the prodrug and the molecular weight of the polymer. Regardless of the polymer, the relative release rates were propionate greater than butyrate greater than pentanoate. The release of butyrate and pentanoate from the spheres consisting of low-molecular-weight polymer (M(r), 65,000) was faster than that from the spheres of higher molecular weight (M(r), 135,000 or 450,000). A single intraperitoneal injection of spheres of the highest molecular weight polymer containing butyrate or pentanoate resulted in higher antitumor effects against P388 leukemia in mice than did free prodrugs given over a period of five consecutive days. The polymer sphere itself showed low toxicity to and good biocompatibility with mice and rats.